iSpecimen (ISPC) Income from Continuing Operations (2020 - 2026)
iSpecimen (ISPC) posted quarterly Income from Continuing Operations of 2652125.0 for Q1 2026, down 46.26% year-over-year from 4935436.21 in Q1 2025, and up 7.65% quarter-over-quarter from 2871925.0 in Q4 2025.
iSpecimen (ISPC) Income from Continuing Operations (2020 - 2026) Analysis & Trends
iSpecimen's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 2652125.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 46.26% year-over-year to 2652125.0; the TTM figure through Mar 2026 stood at 10519307.0 (up 17.56% YoY), while the FY2025 annual figure was 9663113.0, up 31.84% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 2652125.0, up from 2871925.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 1711533.0 in Q3 2024, with the low at 6305844.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 2829933.0 (2025), against an average of 2909354.65.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations tumbled 110.81% in 2022, then jumped 54.46% in 2025.
- iSpecimen's Income from Continuing Operations stood at 2082297.0 in 2022, then slumped by 52.1% to 3167156.0 in 2023, then plunged by 99.1% to 6305844.0 in 2024, then soared by 54.46% to 2871925.0 in 2025, then increased by 7.65% to 2652125.0 in 2026.
- Business Quant data shows ISPC's Income from Continuing Operations at 2652125.0 in Q1 2026, 2871925.0 in Q4 2025, and 2829933.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 324.00 Mn |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 | -2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.65 Mn |
| Dec 31, 2025 | -2.87 Mn |
| Sep 30, 2025 | -2.83 Mn |
| Jun 30, 2025 | -2.17 Mn |
| Mar 31, 2025 | -1.81 Mn |
| Dec 31, 2024 | -6.31 Mn |
| Sep 30, 2024 | -1.71 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -3.38 Mn |
| Dec 31, 2023 | -3.17 Mn |
| Sep 30, 2023 | -2.37 Mn |
| Jun 30, 2023 | -3.69 Mn |
| Mar 31, 2023 | -2.68 Mn |
| Dec 31, 2022 | -2.08 Mn |
| Sep 30, 2022 | -3.27 Mn |
| Jun 30, 2022 | -2.69 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -1.99 Mn |
| Sep 30, 2021 | -1.55 Mn |
| Jun 30, 2021 | -1.39 Mn |